P53 downregulates Down syndrome-associated DYRK1A through miR-1246

EMBO Reports

Volumn 12, Issue 8, 2011, Pages 811-817

  Zhang, Yu ^a,b   Liao, Jun Ming ^a   Zeng, Shelya X ^a   Lu, Hua ^a  

^a INDIANA UNIVERSITY   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Down syndrome; DYRK1A; miR 1246; NFATc1; p53

Indexed keywords

BETA ACTIN; MICRORNA; PROTEIN DYRK1A; PROTEIN KINASE; PROTEIN NFATC1; PROTEIN P21; PROTEIN P53; PROTEIN P63; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; DOWN SYNDROME; GENE EXPRESSION; GENE INDUCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION;

APOPTOSIS; CELL LINE, TUMOR; DNA DAMAGE; DOWN SYNDROME; DOWN-REGULATION; HCT116 CELLS; HUMANS; MICRORNAS; NFATC TRANSCRIPTION FACTORS; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79961022039     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/embor.2011.98     Document Type: Article

References (31)

1. Arron JR et al (2006) NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441:595-600 (Pubitemid 43927286)
2. Baek KH et al (2009) Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 459:1126-1130
3. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215-233
4. Beals CR, Sheridan CM, Turck CW, Gardner P, Crabtree GR (1997) Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275:1930-1934
5. Becker W, Weber Y, Wetzel K, Eirmbter K, Tejedor FJ, Joost HG (1998) Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases. J Biol Chem 273:25893-25902 (Pubitemid 28475820)
6. Belyi VA, Ak P, Markert E, Wang H, Hu W, Puzio-Kuter A, Levine AJ (2010) The origins and evolution of the p53 family of genes. Cold Spring Harb Perspect Biol 2:a001198
7. Braun CJ, Zhang X, Savelyeva I, Wolff S, Moll UM, Schepeler T, Orntoft TF, Andersen CL, Dobbelstein M (2008) p53-Responsive microRNAs 1 92 and 21 5 are capable of inducing cell cycle arrest. Cancer Res 68:10094-10104
8. da Costa Martins PA et al (2010) MicroRNA-1 99b targets the nuclear kinase Dyrkla in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol 12:1220-1227
9. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A (1992) Mice deficient for pS3 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-221
10. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of pS3 tumor suppression. Cell 75:817-825 (Pubitemid 23346378)
11. Fernandez F, Morishita W, Zuniga E, Nguyen J, Blank M, Malenka RC, Garner CC (2007) Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat Neurosci 10:411-413 (Pubitemid 46494581)
12. Guimera J, Casas C, Pucharcos C, Solans A, Domenech A, Planas AM, Ashley J, Lovett M, Estivill X, Pritchard MA (1996) A human homologue of Drosophila minibrain (MNB) is expressed in the neuronal regions affected in Down syndrome and maps to the critical region. Hum Mol Genet 5:1305-1310 (Pubitemid 26335848)
13. Gwack Y et al (2006) A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT. Nature 441:646-650 (Pubitemid 43927297)
14. He L et al (2007) A microRNA component of the p53 tumour suppressor network. Nature 447:1130-1134 (Pubitemid 47014436)
15. Kline J, Kinney A, Levin B, Mayeux R, Schupf N, Warburton D (2000) Alzheimer's disease in the parents of women with trisomic spontaneous abortions. Neuroreport 11:795-799 (Pubitemid 30173926)
16. Laguna A, Aranda S, Barallobre MJ, Barhoum R, Fernandez E, Fotaki V, Delabar JM, de la Luna S, de la Villa P, Arbones ML (2008) The protein kinase DYRK1A regulates caspase-9-mediated apoptosis during retina development. Dev Cell 15:841-853
17. Midgley CA, Lane DP (1997) p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding. Oncogene 15:1179-1189 (Pubitemid 27429621)
18. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398:708-713 (Pubitemid 29197649)
19. Nair AP, Hahn S, Banholzer R, Hirsch HH, Moroni C (1994) Cyclosporin A inhibits growth of autocrine tumour cell lines by destabilizing interleukin-3 mRNA. Nature 369:239-242 (Pubitemid 24154802)
20. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M (2007) Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26:731-743 (Pubitemid 46856247)
21. Ryeom S, Baek KH, Rioth MJ, Lynch RC, Zaslavsky A, Birsner A, Yoon SS, McKeon F (2008) Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth. Cancer Cell 13:420-431 (Pubitemid 351609439)
22. Sachdeva M, Zhu S, Wu F, Wu H, Walia V, Kumar S, Elble R, Watabe K, Mo YY (2009) p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA 106:3207-3212
23. Sampath D, Calin GA, Puduvalli VK, Gopisetty G, Taccioli C, Liu CG, Ewald B, Liu C, Keating MJ, Plunkett W (2009) Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation. Blood 113:3744-3753
24. Shaw JP, Utz PJ, Durand DB, Toole JJ, Emmel EA, Crabtree GR (1988) Identification of a putative regulator of early T cell activation genes. Science 241:202-205
25. Song WJ et al (1996) Isolation of human and murine homologues of the Drosophila minibrain gene: human homologue maps to 21q22.2 in the Down syndrome 'critical region'. Genomics 38:331-339
26. Stiewe T (2007) The p53 family in differentiation and tumorigenesis. Nat Rev Cancer 7:165-168
27. Su X, Chakravarti D, Cho MS, Liu L, Gi YJ, Lin YL, Leung ML, El-Naggar A, Creighton CJ, Suraokar MB, Wistuba I, Flores ER (2010) TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature 467:986-990
28. Wu X, Nguyen BC, Dziunycz P, Chang S, Brooks Y, Lefort K, Hofbauer GF, Dotto GP (2010) Opposing roles for calcineurin and ATF3 in squamous skin cancer. Nature 465:368-372
29. Xanthoudakis S, Viola JP, Shaw KT, Luo C, Wallace JD, Bozza PT, Luk DC, Curran T, Rao A (1996) An enhanced immune response in mice lacking the transcription factor NFAT1. Science 272:892-895
30. Yang A et al (2000) p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404:99-103 (Pubitemid 30143141)
31. Zeng SX, Dai MS, Keller DM, Lu H (2002) SSRP1 functions as a co-activator of the transcriptional activator p63. EMBO J 21:5487-5497 (Pubitemid 35231028)